Adenocarcinoma of the Pancreas Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00366457Gemcitabine, Bevacizumab and Erlotinib in Pancreatic CancerTreatment
NCT00114179Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryTreatment
NCT00091026Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic CancerTreatment
NCT00028834Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerTreatment